Operating Costs (USD, thousands)

Research and Development Expenses (USD, thousands)

Selling, General and Administrative Expenses (USD, thousands)

Total Operating Costs and Expenses (USD, thousands)

Interest Expense (USD, thousands)

Interest Expense (Income), Net (USD, thousands)

Change in Fair Value of Warrants (USD, thousands)

Other Expense (USD, thousands)

Total Other (Income) Expense (USD, thousands)

Net Income (Loss) (USD, thousands)

1eab8f246223b821f0f8bc42c8c608533ae6467e0c061c56f323ff9a3633b594

Net cash used in operating activities (USD, thousands)

Net cash provided by (used in) investing activities (USD, thousands)

Net cash provided by (used in) financing activities (USD, thousands)

Cash and cash equivalents, beginning of period (USD, thousands)

Cash and cash equivalents, end of period (USD, thousands)

b738cb7031a0a4d89bab7e59835fec652e50328de3f70fe3207f5fcd774f1cc0

Cash and cash equivalents (USD, thousands)

Restricted cash – current (USD, thousands)

Inventory (USD, thousands)

Prepaid expenses and other current assets (USD, thousands)

Total current assets (USD, thousands)

Restricted cash – non-current (USD, thousands)

Prepaid expenses and other non-current assets (USD, thousands)

Operating lease right-of-use assets (USD, thousands)

Property, plant and equipment, net (USD, thousands)

TOTAL ASSETS (USD, thousands)

Accounts payable (USD, thousands)

Accrued expenses (USD, thousands)

Accrued interest (USD, thousands)

Current portion of warrant liability (USD, thousands)

Current portion of long-term debt (USD, thousands)

Current portion of related party bonds payable (USD, thousands)

Total current liabilities (USD, thousands)

Deferred revenue (USD, thousands)

Long-term debt, less current portion (USD, thousands)

Related party bonds payable (USD, thousands)

Warrant liability (USD, thousands)

Operating lease right-of-use liabilities (USD, thousands)

Preferred stock liability (USD, thousands)

Other non-current liabilities (USD, thousands)

TOTAL LIABILITIES (USD, thousands)

Common Stock (USD, thousands)

Additional paid-in capital (USD, thousands)

Accumulated other comprehensive income (loss) (USD, thousands)

Accumulated deficit (USD, thousands)

TOTAL STOCKHOLDERS' EQUITY (USD, thousands)

TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY (USD, thousands)

404cae0c2618059334b0a63f541d1e10f8a4c44f0937b5206d906fbc37a416bc

Adjustments for Non-Cash Items (USD, thousands)

Stock-Based Compensation (USD, thousands)

Changes in Working Capital (USD, thousands)

Capital Expenditures (CapEx) (USD, thousands)

Proceeds from / Repayments of Debt (USD, thousands)

Share Repurchases (USD, thousands)

Dividend Payments (USD, thousands)

Net Change in Cash (USD, thousands)

faee24e9cb0441ca4a62ba7d1adb4c13a7774af11fdfa2d07a0c74df07395c4e

Current Assets (USD, thousands)

Cash and Cash Equivalents (USD, thousands)

Accounts Receivable (USD, thousands)

Non-Current Assets (USD, thousands)

Property, Plant, and Equipment (PP&E) (USD, thousands)

Goodwill (USD, thousands)

Intangible Assets (USD, thousands)

Current Liabilities (USD, thousands)

Accounts Payable (USD, thousands)

Short-term Debt (USD, thousands)

Accrued Expenses (USD, thousands)

Non-Current Liabilities (USD, thousands)

Long-term Debt (USD, thousands)

Lease Liabilities (USD, thousands)

Deferred Tax Liabilities (USD, thousands)

Shareholders' Equity (USD, thousands)

Retained Earnings (USD, thousands)

Additional Paid-in Capital (USD, thousands)

acbe7a1e65825b0bbcf8eed425a242a1cbafdc0b4786095b7f0c2a5dadd8e6db

UPR resin production capacity for the Ironton Facility (million pounds per year)

UPR resin production capacity for each purification line at the Augusta Facility (million pounds per year)

UPR resin production capacity for all lines at the Augusta Facility (million pounds per year)

PureCycle Technologies (PCT)

Financials